Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th August, 2021 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

 1. Copy of the Limited Review Report of the Statutory Auditors of the Company, M/s. NDJ & Co, Chartered Accountants, (Firm Registration No. 136345W), on the Un-audited Consolidated Financial Results; 2. Copy of the Un-audited Consolidated Financial Results of the Company for the quarter ended 30th June, 2021 of the Current Financial Year 2021-22; 3. Copy of the Limited Review Report of the Statutory Auditors of the Company, M/s. NDJ & Co, Chartered Accountants, (Firm Registration No. 136345W), on the Un-audited Standalone Financial Results; 4. Copy of the Un-audited Standalone Financial Results of the Company for the quarter ended 30th June, 2021 of the Current Financial Year 2021-22;
14-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th August, 2021 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

 1. Copy of the Limited Review Report of the Statutory Auditors of the Company, M/s. NDJ & Co, Chartered Accountants, (Firm Registration No. 136345W), on the Un-audited Consolidated Financial Results; 2. Copy of the Un-audited Consolidated Financial Results of the Company for the quarter ended 30th June, 2021 of the Current Financial Year 2021-22; 3. Copy of the Limited Review Report of the Statutory Auditors of the Company, M/s. NDJ & Co, Chartered Accountants, (Firm Registration No. 136345W), on the Un-audited Standalone Financial Results; 4. Copy of the Un-audited Standalone Financial Results of the Company for the quarter ended 30th June, 2021 of the Current Financial Year 2021-22;
14-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 In continuation of the previous announcement dated 11th August,2021 , the Investors' Conference call to discuss the financials and operational performance for the quarter ended June 30, 2021 (Q1 FY 22) will be held on Monday, August 16, 2021 at 4.00 P.M. (IST). Link for the said meeting is enclosed.
13-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 The Investors' Conference call to discuss the financials and operational performance for the quarter ended June 30, 2021 (Q1 FY 22) will be held on Monday, August 16, 2021 at 4.00 P.M. (IST)
11-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Shareholding for the Period Ended July 28, 2021

 Tatva Chintan Pharma Chem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended July 28, 2021. For more details, kindly Click here
11-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter Ended June 2021

 Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve 1. the unaudited Standalone financial results of the Company for the quarter ended 30 June 2021 and 2. the unaudited Consolidated financial results of the Company for the quarter ended 30 June 2021.
06-08-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window

 We would like to inform you that, pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and Company''s Code on Prohibition of Insider Trading, the 'Trading Window' for dealing in the Equity shares of the Company shall remain closed for all Designated persons and their immediate relatives from Thursday, 29 July 2021 till the completion of 48 hours after the declaration of Un-audited Financial Results of the Company for the First Quarter (Three Months) ended on 30th June, 2021 of the Current Financial year 2021-22.
29-07-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Listing of equity shares of Tatva Chintan Pharma Chem Ltd

 Trading Members of the Exchange are hereby informed that effective from July 29, 2021, the equity shares of Tatva Chintan Pharma Chem Ltd (Scrip Code: 543321) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20210728-25 dated July 28, 2021.
29-07-2021

Tatva Chintan Pharma Chem: Pre-IPO Call with Management

 Pre-IPO Conference Call with Tatva Chintan Pharma Chem Management and Analysts on the company's performance, outlook and post-listing plans. Watch the full transcript.
13-07-2021
Close

Let's Open Free Demat Account